Titanium dioxide
Anthelios (titanium dioxide) is a small molecule pharmaceutical. Titanium dioxide was first approved as Anthelios 20 on 2006-10-05.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
Combinations
Anthelios
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| abalone crystaldouble ex bb | unapproved drug other | 2017-03-10 |
| abalone crystaldouble ex cc | unapproved drug other | 2017-03-10 |
| absolute total bb spf37 pa 3plus | OTC monograph final | 2011-12-01 |
| al0039006 alba sport sunscreen fragrance free spf45 | OTC monograph not final | 2021-04-12 |
| al0082706 alba botanica hw sunscreen green tea spf45 | OTC monograph not final | 2021-04-12 |
| alba hawaiian aloe vera sunblock spf 30 | OTC monograph not final | 2010-07-14 |
| alba hawaiian green tea sunblock spf 45 | OTC monograph not final | 2010-07-13 |
| alba hawaiian sunscreen green tea spf45 | OTC monograph not final | 2014-11-14 |
| alba hw sunscreen soothing aloe vera spf30 | OTC monograph not final | 2014-11-26 |
| alba sunblock natural facial spf 30 | OTC monograph not final | 2010-07-09 |
Show 186 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
122 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Acute coronary syndrome | D054058 | EFO_0005672 | — | — | — | — | 2 | 1 | 3 |
| Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | 1 | 2 | 3 |
| Infections | D007239 | EFO_0000544 | — | — | — | 2 | 1 | — | 3 |
| Osteoarthritis | D010003 | EFO_0002506 | M15-M19 | — | — | — | 1 | 1 | 2 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | 2 | — | 2 |
| Rheumatoid arthritis | D001172 | EFO_0000685 | M06.9 | — | — | — | 1 | — | 1 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | — | 1 | — | 1 |
| Percutaneous coronary intervention | D062645 | — | — | — | — | — | 1 | — | 1 |
| Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | — | 1 | — | 1 |
| Relapsing-remitting multiple sclerosis | D020529 | EFO_0003929 | — | — | — | — | 1 | — | 1 |
Show 5 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dental caries | D003731 | EFO_0003819 | K02 | — | — | 1 | — | 2 | 3 |
| Covid-19 | D000086382 | — | U07.1 | — | — | 2 | — | — | 2 |
| Hemorrhage | D006470 | MP_0001914 | R58 | — | — | 2 | — | — | 2 |
| Postoperative complications | D011183 | — | — | — | — | 2 | — | — | 2 |
| Gestational diabetes | D016640 | HP_0009800 | O24.4 | — | — | 1 | — | — | 1 |
| Rhinitis | D012220 | EFO_0008521 | J31 | — | — | 1 | — | — | 1 |
| Pulpitis | D011671 | EFO_1001139 | K04.0 | — | — | 1 | — | — | 1 |
| Sars-cov-2 | D000086402 | — | — | — | — | 1 | — | — | 1 |
| Medulloblastoma | D008527 | — | — | — | — | 1 | — | — | 1 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | 1 | — | — | 1 |
Show 1 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Healthy volunteers/patients | — | — | — | 2 | 1 | — | — | — | 3 |
| Pinealoma | D010871 | — | — | — | 1 | — | — | 1 | 2 |
| Sjogren's syndrome | D012859 | EFO_0000699 | M35.0 | 1 | 1 | — | — | 1 | 2 |
| Castration-resistant prostatic neoplasms | D064129 | — | — | — | 2 | — | — | — | 2 |
| Candidiasis | D002177 | — | B37 | — | 1 | — | — | 1 | 2 |
| Bronchiectasis | D001987 | HP_0002110 | J47 | — | 1 | — | — | — | 1 |
| Renal cell carcinoma | D002292 | EFO_0000376 | — | — | 1 | — | — | — | 1 |
| Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | 1 | — | — | — | 1 |
| Neuroblastoma | D009447 | EFO_0000621 | — | — | 1 | — | — | — | 1 |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | — | — | — | 1 |
Show 13 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Denture stomatitis | D013282 | EFO_1000893 | K12.1 | 1 | — | — | — | 2 | 3 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 1 | — | — | — | 1 | 2 |
| Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | — | — | — | 1 | 2 |
| Hiv | D006678 | — | O98.7 | 1 | — | — | — | — | 1 |
| Medication adherence | D055118 | EFO_0006344 | — | 1 | — | — | — | — | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | 1 | — | — | — | — | 1 |
| Prostatic hyperplasia | D011470 | EFO_0000284 | N40 | 1 | — | — | — | — | 1 |
| Brain neoplasms | D001932 | EFO_0003833 | C71 | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Peri-implantitis | D057873 | EFO_1001390 | — | — | — | — | — | 2 | 2 |
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 2 | 2 |
| Microbiota | D064307 | — | — | — | — | — | — | 2 | 2 |
| Carotid stenosis | D016893 | — | — | — | — | — | — | 1 | 1 |
| Inferior wall myocardial infarction | D056989 | EFO_1000983 | — | — | — | — | — | 1 | 1 |
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 1 | 1 |
| Premenstrual syndrome | D011293 | — | N94.3 | — | — | — | — | 1 | 1 |
| Back pain | D001416 | HP_0003418 | M54 | — | — | — | — | 1 | 1 |
| Xerostomia | D014987 | — | K11.7 | — | — | — | — | 1 | 1 |
| Urinary tract infections | D014552 | EFO_0003103 | N39.0 | — | — | — | — | 1 | 1 |
Show 33 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Titanium dioxide |
| INN | — |
| Description | Titanium dioxide is a titanium oxide with the formula TiO2. A naturally occurring oxide sourced from ilmenite, rutile and anatase, it has a wide range of applications. It has a role as a food colouring. |
| Classification | Small molecule |
| Drug class | quaternary ammonium derivatives |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | 13463-67-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL1201136 |
| ChEBI ID | 32234 |
| PubChem CID | 26042 |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 88,901 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
473 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use